At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 103 enrolled
Drug / intervention
Ropivacaine +1 moredrug
Likely dose
Ropivacaine 15 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Ultrasound Guided Supraclavicular Nerve Block: Comparison Between a Mixture of Mepivacaine and Ropivacaine, and Sequential Injection of Mepivacaine Followed by Ropivacaine
In Brief
A Phase 3 clinical trial evaluating Ropivacaine and Mepivacaine for Local Anesthetic. Completed, enrolled 103 participants across 1 site.
Detailed Summary
This study will test the hypothesis that sequential injection of 1.5% mepivacaine followed 90 seconds later by 0.5% ropivacaine in ultrasound guided supraclavicular block provides a quicker onset and a longer duration of analgesia than an equi-dose mixture of the two local anesthetics.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLocal Anesthetic
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartSep 2008
First PostedJan 2009
Primary CompletionAug 2010
TodayJul 2026
First PostedJan 21, 2009
Enrollment StartSep 1, 2008
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 17.4 years ago
Interventions
Ropivacainedrug
ropivacaine (15 ml).
Mepivacainedrug
One syringe will contain mepivacaine (15 ml)